All data are based on the daily closing price as of October 28, 2026
e
Euglena
2931.TSE
2.05 USD
-0.04
-1.91%
Overview
Last close
2.05 usd
Market cap
286.48M usd
52 week high
3.46 usd
52 week low
1.97 usd
Target price
2.54 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.8798
Price/Book Value
1.3959
Enterprise Value
330.87M usd
EV/Revenue
0.9977
EV/EBITDA
7.9831
Key financials
Revenue TTM
331.65M usd
Gross Profit TTM
229.59M usd
EBITDA TTM
42.29M usd
Earnings per Share
-0.01 usd
Dividend
0.01 usd
Total assets
426.12M usd
Net debt
59.37M usd
About
Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and social businesses; and invests in biotechnology related businesses. Further, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.